Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: pre-treatment with duphaston: in these patients, along with the routine protocol of frozen embryo transfer, duphaston 10 mg daily is prescribed from the 15th to the
leuprorelin acetate, Iran) on the 21st day of the previous menstrual cycle It will be injected subcutaneously, from the 15th to the 25th day of the cycle, Duphaston 10 mg is prescribed daily.
Sponsors
Avicenna Infertility Clinic
Eligibility
Sex/Gender
Female
Age
20 Years to 39 Years
Inclusion criteria
Inclusion criteria: Having PCOS according to the Rotterdam criteria (oligomenorrhea, hyperandrogenism or hyperandrogenemia and polycystic ovary) The age of the lady is more than 20 years 5-day embryo freezing The natural cavity of the uterus Intracytoplasmic sperm injection (ICSI) cycle
Exclusion criteria
Exclusion criteria: The age of the lady is more than 39 years Having a history of endometriosis Having moderate or severe adenomyosis FSH= 12 mIU/mL Surrogate mothers A history of more than 3 previous failed embryo transfers Sex selection cycles Donation cycles Visibility of hydrosalpinx in ultrasound The presence of any type of uterine abnormalities Presence of submucosal myoma larger than 2 cm Having Asherman syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main outcome under study is the rate of clinical fertility in two treatment groups. Timepoint: ß-hCG serum level is measured on days 14 and 16 after embryo transfer. Method of measurement: Serum ß-hCG level using blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: The tenth day of the menstrual cycle. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Bita Badehnoosh
Avicenna Infertility Clinic
Outcome results
None listed